SECTION 1. Section 1 of chapter 111D of the General Laws, as appearing in the 2016 Official Edition, is hereby amended by inserting the following definition:-

“CLIA-Waived Test”, a test system, assay, or examination that the federal department of health and human services has determined meets the statutory criteria as specified for waiver under section 353(d)(3) of the Public Health Service Act.

SECTION 2. Said section 1 of said chapter 111D, as so appearing, is hereby further amended by striking the definitions for “Complex Laboratory Test” and “Simple Laboratory Test”.

SECTION 3. Said section 1 of said chapter 111D, as so appearing, is hereby further amended by striking the definition for “Exempt Test” and replacing it with the following definition:-

''Exempt test'', a test designated by the department as having a low risk of error, including, but not limited to, CLIA-waived tests and provider-performed microscopy.

SECTION 4. Subsection (9) of section 2 of said chapter 111D, as so appearing, is hereby amended by striking the following words:- “simple or complex,”

SECTION 5. Said section 2 of said chapter 111D, as so appearing, is hereby further amended by inserting at the end thereof the following subsection:-

(10) to establish minimum qualifications of clinical laboratory directors.

SECTION 6. Said chapter 111D, as so appearing, is hereby further amended by striking section 7 in its entirety.

SECTION 7. Section 8 of said Chapter 111D, as so appearing, is hereby amended by striking subsections (7) and (8).

SECTION 8. Subsection (11) of said section 8 of said chapter 111D is hereby amended by striking out the words “except as provided in section seven;”, and inserting in place thereof the following:- who does not meet the department’s minimum qualifications for a laboratory director;